Picture of Genelink logo

GNLKQ Genelink Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Genelink, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2008
December 31st
2009
December 31st
C2010
December 31st
2011
December 31st
2012
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.6-2.72-2.63-3.83-3.05
Depreciation
Non-Cash Items0.6250.3620.7340.535-0.23
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.441-0.320.40.2590.685
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-1.45-2.55-1.34-2.9-2.38
Capital Expenditures-0.281-0.121-0.124-0.041-0.242
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.539
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities-0.281-0.121-0.124-0.0410.297
Financing Cash Flow Items0-0.20400.9550
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.22.431.73.251.5
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.537-0.2380.2320.311-0.582